The BMS986340 Biosimilar Anti-CCR8 Antibody is a cutting-edge tool for researchers studying CCR8, a chemokine receptor involved in regulating immune responses. This monoclonal antibody, produced using state-of-the-art technology, is highly specific and sensitive for detecting CCR8 in human samples. It is validated for use in a variety of research applications, including immunohistochemistry and flow cytometry.CCR8 is a key player in the immune system, involved in directing immune cells to sites of inflammation and infection.
By targeting CCR8, researchers can gain insights into immune cell migration and function, paving the way for new treatments for autoimmune diseases, allergies, and inflammatory disorders. The BMS986340 Biosimilar Anti-CCR8 Antibody is a valuable tool for investigating the role of CCR8 in health and disease, making it an essential addition to any immunology or cancer research laboratory.
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
4A19, BMS-986340
Description:
Anti-CCR8(BMS 986340) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
